View Single Post
  #8 (permalink)  
Old 10th January 2010, 05:43 AM
Dr. Geoffrey Nase's Avatar
Dr. Geoffrey Nase Dr. Geoffrey Nase is offline
Administrator
 
Join Date: Sep 2009
Location: USA - Indiana/Pennsylvania
Posts: 214
Dr. Geoffrey Nase has a reputation beyond reputeDr. Geoffrey Nase has a reputation beyond reputeDr. Geoffrey Nase has a reputation beyond reputeDr. Geoffrey Nase has a reputation beyond reputeDr. Geoffrey Nase has a reputation beyond reputeDr. Geoffrey Nase has a reputation beyond reputeDr. Geoffrey Nase has a reputation beyond reputeDr. Geoffrey Nase has a reputation beyond reputeDr. Geoffrey Nase has a reputation beyond reputeDr. Geoffrey Nase has a reputation beyond reputeDr. Geoffrey Nase has a reputation beyond repute
Default

Quote:
Originally Posted by Barbara View Post
Dr. Nase,

thanks, I'm looking forward to any news about the development of Sansrosa. Again Thank you for all your time and effort you are putting in this board.

The Dose-Finding-Study (Phase II) of Sansrosa has been completed now.
Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea - Full Text View - ClinicalTrials.gov

Barbara

Good stuff Barbara. It takes a while to publish, so they are full tilt into Phase III trials. Time release, the right concentration and the proper base could make for the best topical yet.

_
__________________
_

Best,
Geoffrey

Dr. Geoffrey Nase
Ph.D: Neuro-Vascular Physiologist

Email: drnase1000@hotmail.com
Bibliography: http://drnase.com

All posts are for informational purposes only. Please visit our Home Page to view our Medical Disclaimer.
Reply With Quote